Long-Term Safety of Ixekizumab for Psoriasis: A Review of Key Findings

https://is1-ssl.mzstatic.com/image/thumb/Podcasts211/v4/94/0d/5a/940d5aff-31ff-ff33-0bd9-c96fe92b6888/mza_17295708488901997546.png/600x600bb.jpg

On the Frontlines of Psoriasis

ReachMD

20 episodes

3 months ago

Stay up to date on the latest advancements in the management of one of the most common types of skin diseases with our exclusive podcast series, On the Frontlines of Psoriasis. Tune in to hear from leading dermatology experts as they explore key diagnosis and treatment strategies in addition to the ongoing research that’s reshaping our understanding of this common and chronic disease.

Science

Medicine

RSS

All content for On the Frontlines of Psoriasis is the property of ReachMD and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Science

Medicine

Long-Term Safety of Ixekizumab for Psoriasis: A Review of Key Findings

On the Frontlines of Psoriasis

8 months ago

Long-Term Safety of Ixekizumab for Psoriasis: A Review of Key Findings

Guest: Atul A. Deodhar, MD, MRCP

Managing psoriasis, psoriatic arthritis, and axial spondyloarthritis with ixekizumab may cause adverse effects in patients. That’s why a recent research review further investigated the safety of this treatment over time, analyzing data from 25 clinical trials and noting common side effects. Learn more about ixekizumab’s long-term use with Dr. Atul Deodhar, the lead author of this study. He’s also a Professor of Medicine and the Medical Director of Rheumatology Clinics at Oregon Health & Science University.